MSMichael E. Saladin

Michael E. Saladin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael E. Saladin has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Written Exposure Therapy for PTSD Integrated with Cognitive Behavioral Coping Skills for Cannabis Use Disorder After Recent Sexual Assault: A Case Series

    by Christine K. Hahn, Selime R. Salim, Emily L. Tilstra-Ferrell, Kathleen T. Brady, Brian P. Marx, Barbara O. Rothbaum, Michael E. Saladin, Constance Guille, Amanda K. Gilmore, Sudie E. Back

    Background/Objectives: The co-occurrence of posttraumatic stress disorder (PTSD) and cannabis use disorder (CUD) symptoms is common following sexual assault, particularly among emerging adult women. CUD is associated with more severe PTSD symptoms and other mental health comorbidities including depression, suicidality, and emotion dysregulation. Addressing these issues concurrently soon after sexual assault could help decrease the risk for downstream negative health outcomes. Integrated trauma-focused interventions for PTSD and co-occurring substance use disorders have been shown to decrease PTSD severity and substance use. Yet, existing protocols are lengthy and have rarely been applied following recent trauma exposure or specifically to address CUD symptoms. Methods: This case series describes the application of Written Exposure Therapy (WET) for PTSD adapted to integrate cognitive-behavioral skills training for substance use among women following recent sexual assault. The adapted integrated intervention, Skills Training and Exposure for PTSD and Substance Misuse (STEPS), was delivered to three emerging adult women (age range = 19–25) who experienced recent sexual assault (weeks since assault range = 1–12 weeks). Results: This case series describes the novel intervention and examines clinical outcomes post-treatment and at the 1-month follow-up. Past-week PTSD symptoms (based on a clinical interview) and past-month cannabis use decreased among all participations after receiving STEPS. Conclusions: Preliminary findings from the case series provide new knowledge and insights regarding the application of STEPS following recent sexual assault among individuals with co-occurring PTSD and CUD. Therapeutic strategies for addressing PTSD and CUD concurrently and implications for future clinical research are discussed.


  • Prospects for reconsolidation-focused treatments of substance use and anxiety-related disorders

    by Daniel J Paulus, Sunjeev K Kamboj, Ravi K Das, Michael E Saladin


  • Intolerance for smoking abstinence among nicotine-deprived, treatment-seeking smokers

    by Lisa J. Germeroth, Nathaniel L. Baker, Michael E. Saladin


  • Open Access

    Modulation of naturalistic maladaptive memories using behavioural and pharmacological reconsolidation-interfering strategies: A systematic review and meta-analysis of clinical and 'sub-clinical' studies

    by Katie H Walsh, Ravi K Das, Michael E Saladin, Sunjeev K Kamboj

    Consolidated memories can undergo enduring modification through retrieval-dependent treatments that modulate reconsolidation. This has been suggested to represent a potentially transformative clinical strategy for weakening or overwriting the maladaptive memories that underlie substance use and anxiety/trauma-related disorders. However, the ability to modulate naturalistic maladaptive memories may be limited by boundary conditions imposed on reconsolidation by the nature of these memories. As such, the true potential of reconsolidation therapy is currently unknown. Here, we report a meta-analyses of behavioural and pharmacological studies examining retrieval-dependent modulation of reward and threat memories in (sub)clinical substance use and anxiety/trauma respectively. Of 4936 publications assessed for eligibility, 7 studies of substance use, and 9 of anxiety (phobia) and trauma-related symptoms were included in the meta-analyses. Overall, the findings were in the predicted direction, with the majority of effect sizes favouring the Retrieval + Treatment condition. However, the magnitude of effects depended upon the nature of the treatment type, with pharmacological interventions (relative to behavioural strategies) showing a clearer beneficial effect in studies of phobia/trauma and post-retrieval behavioural strategies, a (significantly) larger effect in substance use studies. However, high levels of heterogeneity and small sample sizes limit the strength of conclusions that can be drawn at this stage of inquiry. We hope this review will provide an impetus to address these issues in future research.

  • Open Access

    Effect of a Brief Memory Updating Intervention on Smoking Behavior

    by Lisa J. Germeroth, Matthew J. Carpenter, Nathaniel L. Baker, Brett Froeliger, Steven D. LaRowe, Michael E. Saladin

    The role of learning and memory processes in addiction has been well established in both theory and research.1-6 A fundamental source of this learning occurs when cues chronically paired with drug reward gradually acquire the capacity to elicit a range of conditioned responses, such as craving and physiological reactivity. In the case of nicotine-reinforced smoking addiction, individuals trying to quit smoking commonly report that cue-elicited craving plays a central role in smoking lapses.7-11 Smokers with increased vulnerability to cue-elicited craving and those who experience greater reactivity to cues are less likely to quit successfully.12-15 These findings, together with clinical studies demonstrating that first-line cessation medications have only modest effects on cue-elicited cigarette craving,16-19 suggest that there is a need to develop treatments aimed at reducing cue-induced craving and the associated relapse risk.


  • Open Access

    Determining menstrual phase in human biobehavioral research: A review with recommendations.

    by Alicia M. Allen, Aimee L. McRae-Clark, Samantha Carlson, Michael E. Saladin, Kevin M. Gray, Cora Lee Wetherington, Sherry A. McKee, Sharon S. Allen

    Given the volume and importance of research focusing on menstrual phase, a review of the strategies being used to identify menstrual phase and recommendations that will promote methodological uniformity in the field is needed. We conducted a literature review via Ovid Medline and PsycINFO. Our goal was to review methods used to identify menstrual phase and subphases in biobehavioral research studies with women who had physiologically natural menstrual cycles. Therefore, we excluded articles that focused on any of the following: use of exogenous hormones, the postpartum period, menstrual-related problems (e.g., polycystic ovarian syndrome, endometriosis), and infertility/anovulation. We also excluded articles on either younger (45 years old) study samples. We initially identified a total of 1,809 articles. After our exclusionary criteria were applied, 146 articles remained, within which our review identified 6 different methods used to identify menstrual phase and subphases. The most common method used was self-report of onset of menses (145/146 articles) followed by urine luteinizing hormone testing (50/146 articles) and measurement of hormones (estradiol and/or progesterone) in blood samples (49/146 articles). Overall, we found a lack of consistency in the methodology used to determine menstrual phase and subphases. We provide several options to improve accuracy of phase identification, as well as to minimize costs and burden. Adoption of these recommendations will decrease misclassification within individual studies, facilitate cross-study comparisons, and enhance the reproducibility of results.


  • Determining menstrual phase in substance use research: A review with recommendations

    by Alicia M. Allen, Aimee McRae-Clark, Michael E. Saladin, Kevin M. Gray, Cora Lee Wetherington, Sherry A. McKee, Sharon Allen


  • Increasing Progesterone Levels Are Associated With Smoking Abstinence Among Free-Cycling Women Smokers Who Receive Brief Pharmacotherapy

    by Michael E. Saladin, Erin A. McClure, Nathaniel L. Baker, Matthew J. Carpenter, Viswanathan Ramakrishnan, Karen J. Hartwell, Kevin M. Gray

    Preclinical and human laboratory research suggests that (a) progesterone may decrease drug reward, craving, and smoking behavior, and (b) estradiol may enhance drug reward and smoking behavior. A modest majority of treatment research examining the relationship between menstrual cycle phase and outcomes suggests that the luteal menstrual phase, with its uniquely higher progesterone levels, is associated with better cessation outcomes. However, no studies to date have examined the effects of naturally occurring variation in progesterone and estradiol levels on medication-assisted smoking cessation. The present study sought to fill this notable gap in the treatment literature. Weekly plasma progesterone and estradiol levels were obtained from nicotine-dependent female smokers enrolled in a 4-week cessation trial. Participants (N = 108) were randomized to receive a 4-week course of either varenicline (VAR) tablets and placebo patches or placebo tablets and nicotine patches. Plasma samples were obtained 1 week before their cessation attempt and weekly during medication administration. Abstinence was assessed weekly. Weekly hormone data replicated commonly observed menstrual cycle patterns of progesterone and estradiol levels. Importantly, increases in progesterone level were associated with a 23% increase in the odds for being abstinent within each week of treatment. This effect was driven primarily by nicotine patch–treated versus VAR-treated females. This study was the first to identify an association between progesterone level (increasing) and abstinence outcomes in free-cycling women smokers who participated in a medication-based treatment. Furthermore, the potential benefits of progesterone may vary across different pharmacotherapies. Implications of these findings for smoking cessation intervention are discussed.


  • Caffeine and alcohol intake and nicotine dependence severity in female smokers

    by Christine Riyad, Kevin M. Gray, Michael E. Saladin